BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36772932)

  • 1. Assessment of knowledge, understanding and awareness of Chinese women clinical staff towards menopause hormone therapy: a survey study.
    Zhu Y; Yang X; Wang Y; Zhu X
    J Obstet Gynaecol; 2023 Dec; 43(1):2171779. PubMed ID: 36772932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy: what are the problems in the perception of Chinese physicians?
    Deng Y; Wang W; Zheng Q; Feng Y; Zou Y; Dong H; Tan Z; Zeng X; Zhao Y; Peng D; Yang X; Sun A
    Climacteric; 2022 Aug; 25(4):413-420. PubMed ID: 35438051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
    Trémollieres FA; André G; Letombe B; Barthélemy L; Pichard A; Gelas B; Lopès P
    Maturitas; 2022 Dec; 166():58-64. PubMed ID: 36058119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and attitudes of health professionals regarding menopausal hormone therapies.
    Yeganeh L; Boyle J; Teede H; Vincent A
    Climacteric; 2017 Aug; 20(4):348-355. PubMed ID: 28379046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.
    Anagnostis EA
    J Pharm Pract; 2012 Jun; 25(3):324-30. PubMed ID: 22550160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study.
    Ran SY; Yu Q; Chen Y; Lin SQ
    Climacteric; 2017 Aug; 20(4):391-396. PubMed ID: 28523945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing quality of life in perimenopause: lessons from the East.
    Wang X; Ran S; Yu Q
    Climacteric; 2019 Feb; 22(1):34-37. PubMed ID: 30407085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper.
    Genazzani AR; Divakar H; Khadilkar SS; Monteleone P; Evangelisti B; Galal AF; Priego PIR; Simoncini T; Giannini A; Goba G; Benedetto C
    Int J Gynaecol Obstet; 2024 Feb; 164(2):516-530. PubMed ID: 38178609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.
    Mendoza N; Ramírez I; de la Viuda E; Coronado P; Baquedano L; Llaneza P; Nieto V; Otero B; Sánchez-Méndez S; de Frutos VÁ; Andraca L; Barriga P; Benítez Z; Bombas T; Cancelo MJ; Cano A; Branco CC; Correa M; Doval JL; Fasero M; Fiol G; Garello NC; Genazzani AR; Gómez AI; Gómez MÁ; González S; Goulis DG; Guinot M; Hernández LR; Herrero S; Iglesias E; Jurado AR; Lete I; Lubián D; Martínez M; Nieto A; Nieto L; Palacios S; Pedreira M; Pérez-Campos E; Plá MJ; Presa J; Quereda F; Ribes M; Romero P; Roca B; Sánchez-Capilla A; Sánchez-Borrego R; Santaballa A; Santamaría A; Simoncini T; Tinahones F; Calaf J
    Maturitas; 2022 Dec; 166():65-85. PubMed ID: 36081216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal hormone therapy and breast cancer risk.
    Rozenberg S; Di Pietrantonio V; Vandromme J; Gilles C
    Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101577. PubMed ID: 34535397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What the Women's Health Initiative has taught us about menopausal hormone therapy.
    Chester RC; Kling JM; Manson JE
    Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based survey on menopausal symptoms and treatment use.
    Baquedano L; Coronado P; De la Viuda E; Sánchez S; Otero B; Ramírez I; Llaneza P; Mendoza N
    Climacteric; 2023 Feb; 26(1):47-54. PubMed ID: 36351874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopause hormone treatment after cancer.
    Gompel A
    Climacteric; 2023 Jun; 26(3):240-247. PubMed ID: 37011657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.
    Trémollieres FA; Chabbert-Buffet N; Plu-Bureau G; Rousset-Jablonski C; Lecerf JM; Duclos M; Pouilles JM; Gosset A; Boutet G; Hocke C; Maris E; Hugon-Rodin J; Maitrot-Mantelet L; Robin G; André G; Hamdaoui N; Mathelin C; Lopes P; Graesslin O; Fritel X
    Maturitas; 2022 Sep; 163():62-81. PubMed ID: 35717745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk.
    Tian Y; Lin Y; Qu C; Arndt V; Baurley JW; Berndt SI; Bien SA; Bishop DT; Brenner H; Buchanan DD; Budiarto A; Campbell PT; Carreras-Torres R; Casey G; Chan AT; Chen R; Chen X; Conti DV; Díez-Obrero V; Dimou N; Drew DA; Figueiredo JC; Gallinger S; Giles GG; Gruber SB; Gunter MJ; Harlid S; Harrison TA; Hidaka A; Hoffmeister M; Huyghe JR; Jenkins MA; Jordahl KM; Joshi AD; Keku TO; Kawaguchi E; Kim AE; Kundaje A; Larsson SC; Marchand LL; Lewinger JP; Li L; Moreno V; Morrison J; Murphy N; Nan H; Nassir R; Newcomb PA; Obón-Santacana M; Ogino S; Ose J; Pardamean B; Pellatt AJ; Peoples AR; Platz EA; Potter JD; Prentice RL; Rennert G; Ruiz-Narvaez EA; Sakoda LC; Schoen RE; Shcherbina A; Stern MC; Su YR; Thibodeau SN; Thomas DC; Tsilidis KK; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; White E; Wolk A; Woods MO; Wu AH; Peters U; Gauderman WJ; Hsu L; Chang-Claude J
    Br J Cancer; 2024 Jun; 130(10):1687-1696. PubMed ID: 38561434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?
    Vallejo MS; Witis S; Ojeda E; Mostajo D; Morera F; Meruvia N; Martino M; Lima S; Espinoza MT; Castillo O; Campostrini B; Danckers L; Blümel JE; Tserotas K; Sánchez H; Salinas C; Saavedra J; Rojas JA; Onatra W; Monterrosa A; Montaño A; Martínez J; González E; Gómez G; Calle A; Broutin G; Bencosme A; Arteaga E; Ayala F; Chedraui P
    Climacteric; 2016 Aug; 19(4):387-92. PubMed ID: 27327136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts' perspective.
    Rozenberg S; Panay N; Gambacciani M; Cano A; Gray S; Schaudig K
    Expert Rev Clin Pharmacol; 2023; 16(6):507-517. PubMed ID: 37278023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Menopausal hormonal therapy and cancer risks].
    Lasserre A; Fournier A
    Gynecol Obstet Fertil; 2016; 44(7-8):424-7. PubMed ID: 27451070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emirati Women's Knowledge about the Menopause and Menopausal Hormone Therapy.
    Smail L; Jassim GA; Sharaf KI
    Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32640704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.